This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978
Title: Innovations of Tokio Kamata in Viral Disease Prevention for Fish
Introduction
Tokio Kamata is a notable inventor based in Hikone, Japan. He has made significant contributions to the field of veterinary medicine, particularly in the prevention and treatment of viral diseases in fish. His innovative approach combines chemistry and biology to address a critical issue in aquaculture.
Latest Patents
Kamata holds a patent for a prophylactic, therapeutic, or hygienical agent effective against various virus diseases in fish. This agent comprises at least one enediol compound or a salt thereof, such as ascorbic acid or erythorbic acid, combined with a heavy metal, preferably in the form of a water-soluble salt like copper sulfate. The active agent can be administered to fish orally or parenterally, or through bathing, washing, or breeding in an aqueous solution containing the active agent.
Career Highlights
Tokio Kamata is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been able to apply his expertise in developing solutions for viral diseases in aquatic life. His work has been instrumental in enhancing the health and productivity of fish in aquaculture settings.
Collaborations
Kamata has collaborated with notable colleagues, including Tokuo Sano and Takeo Oshima. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of veterinary medicine.
Conclusion
Tokio Kamata's contributions to the prevention and treatment of viral diseases in fish highlight the importance of innovation in aquaculture. His patent reflects a significant advancement in veterinary medicine, showcasing the potential for improved health outcomes in aquatic species.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
